A Molecular Brake on Retinal Cell Death
A new study published in the Proceedings of the National Academy of Sciences identifies DAPL1 as a critical regulator of retinal pigment epithelium (RPE) cell survival in a model of age-related macular degeneration (AMD). The research demonstrates that DAPL1 functions by inhibiting the formation of mitochondria-associated endoplasmic reticulum membranes (MAMs), a process mediated by the protein GRP75. This inhibition restrains a form of inflammatory programmed cell death known as PANoptosis, which combines features of apoptosis, pyroptosis, and necroptosis. The findings pinpoint a specific molecular pathway linking organelle dynamics and cellular stress responses to the pathogenesis of a major blinding disease, offering a novel potential target for therapeutic intervention to preserve vision.
Study Significance: This research directly connects organelle dynamics and a specific cell death pathway to a major human disease, moving beyond correlation to mechanism. For cell biologists, it highlights how the regulation of inter-organelle contact sites like MAMs can be a decisive factor in cell fate decisions under stress. The identification of DAPL1 provides a precise molecular entry point for developing therapies aimed at modulating cellular senescence and inflammatory death in degenerative conditions, with clear implications for drug discovery pipelines targeting mitochondrial dysfunction and protein homeostasis.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.